Past, present, and future of global health financing: A review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050

Global Burden of Disease Health Financing Collaborator Network

    Research output: Contribution to journalArticlepeer-review

    353 Citations (SciVal)
    Original languageEnglish
    Pages (from-to)2233-2260
    Number of pages28
    JournalThe Lancet
    Volume393
    Issue number10187
    DOIs
    Publication statusPublished (VoR) - 1 Jun 2019

    Funding

    C A Antonio reports personal fees from Johnson & Johnson (Philippines), Inc, outside the submitted work. S Lorkowski reports personal fees from Amgen, Berlin-Chemie, Daiichi Sankyo, MSD Sharp & Dohme, Novo Nordisk, Sanofi-Aventis, Synlab, Unilever, and Upfield; non-financial support from Preventicus outside the submitted work; and is a member of the scientific board of the German Nutrition Society and coauthor of the evidence-based guideline on fat intake and prevention of nutrition-related diseases published by the German Nutrition Society. M Savic reports employment by the GSK group of companies and holds restricted shares in the GSK group of companies. M Shrime reports grants from Mercy Ships and from Damon Runyon Cancer Research Foundation outside the submitted work. All other authors declare no competing interests.

    Fingerprint

    Dive into the research topics of 'Past, present, and future of global health financing: A review of development assistance, government, out-of-pocket, and other private spending on health for 195 countries, 1995-2050'. Together they form a unique fingerprint.

    Cite this